Literature DB >> 21817080

Pros and cons of dabigatran.

Christine M Cheng, Megan R McCurdy, Heather A Wong, Steven R Kayser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21817080     DOI： 10.2146/ajhp110178

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.

Authors:  W Hernandez; E R Gamazon; K Aquino-Michaels; S Patel; T J O'Brien; A F Harralson; R A Kittles; A Barbour; M Tuck; S D McIntosh; J N Douglas; D Nicolae; L H Cavallari; M A Perera
Journal:  Pharmacogenomics J       Date:  2013-09-10       Impact factor: 3.550

2.  What neurosurgeons need to know about dabigatran etexilate (pradax(®)/pradaxa(®)/prazaxa(®)).

Authors:  Christopher Michael Dwyer; Omprakash Damodaran; Michael Heckelmann; Mark Michael Sheridan
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.